Loading
A Mayo Clinic study of how multi-cancer blood tests are used in everyday practice and what people think of them.
Mayo Clinic multi-cancer detection observational cohort (NCT06962995) is an observational study sponsored by Mayo Clinic with National Cancer Institute (NCI). It assesses the incorporation of multi-cancer detection testing into clinical practice, with research blood draws and surveys on attitudes and beliefs.
The registry record, read on 29 October 2026, gives its status as recruiting, with an estimated 1,000 participants, a start on 7 May 2025 and primary completion expected on 30 June 2029.
Shares Multi-cancer early detection (MCED), National Cancer Institute (NIH), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/